Angela Kashuba, PharmD, the John A. and Deborah S. McNeil, Jr. Distinguished Professor in the UNC Eshelman School of Pharmacy, has been awarded $4.4 million over five years by the National Institutes of Health to study drug penetration in the … Read more
Angela Kashuba, PharmD, has been named to the National Institutes of Health Advisory Committee on Research on Women’s Health. Kashuba is the first representative of pharmacy or the pharmaceutical sciences to join the group. The members serve four-year terms and … Read more
Internationally known AIDS and HIV researcher Angela Kashuba, PharmD, has been awarded the John A. and Deborah S. McNeill Jr. Distinguished Professorship at the UNC Eshelman School of Pharmacy. Kashuba studies the role of antiretroviral therapy in preventing the transmission … Read more
A team of scientists from the University of North Carolina at Chapel Hill that includes Professor Angela Kashuba, PharmD, has published pioneering research showing that a drug used to treat certain types of lymphoma could dislodge hidden HIV virus in … Read more
The NIH has funded two additional positions in the T32 clinical pharmacology postdoctoral fellowship program administered by the UNC Eshelman School of Pharmacy in collaboration with Duke University, and the Hamner Institute for Drug Safety Sciences. The additional positions expand … Read more
New research from the University of North Carolina at Chapel Hill schools of medicine and pharmacy may help explain the failure of some recent clinical trials of prevention of HIV infection compared to the success of others that used the … Read more
The University of North Carolina at Chapel Hill Board of Trustees has approved the promotion of Angela Kashuba, PharmD, to the rank of full professor in the UNC Eshelman School of Pharmacy. “In the past thirty years, AIDS has gone … Read more
Scientists at the UNC School of Medicine and UNC Eshelman School of Pharmacy have been awarded a $3 million federal grant to develop and test a new generation of treatments aimed at preventing sexual transmission of HIV to uninfected individuals. … Read more
Angela Kashuba, PharmD, is concerned that the current approach to developing drug therapies to prevent HIV infection is backwards. “We know that administering large doses of HIV drugs in animal models can prevent infection, but this information doesn’t directly help … Read more
Researchers at the University of North Carolina at Chapel Hill have been awarded a five-year, $32 million federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral … Read more
